PTC Therapeutics, Inc. (PTCT) FY2026 Q3 P&L / Income Statement

Published Source: Form 10-Q on SEC EDGAR filed (opens in a new tab)

Revenue by Product and Service (3 categories)

Swipe to see the full flow
PTC Therapeutics, Inc. (PTCT) FY2026 Q3 P&L / Income StatementIncome statement for 2026-07-01 through 2026-09-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEOPERATINGPRE-TAXNETNet product revenueRoyalty revenueCollaboration and license revenueTotal revenuesIncome from operationsTotal operating expensesTotal operating expenses(Loss) income before income tax (expense) benefitOther income (expense), net (calculated)Net (loss) income attributable to common stockholdersIncome tax (expense) benefit(Loss) income before income tax (expense) benefit(Loss) incomebefore income tax(expense) benefit−$41.09 MTotal revenuesTotal revenues$357.81 MIncome from operationsIncome from operations$25.11 MNet (loss) income attributable to common stockholdersNet (loss) incomeattributable tocommon stockholders−$51.69 MTotal operating expensesTotal operatingexpenses$332.69 MNet product revenueNet product revenue$275.89 MIncome tax (expense) benefitIncome tax(expense) benefit$10.61 MTotal operating expensesTotal operating expenses$332.69 MRoyalty revenueRoyalty revenue$81.68 MCollaboration and license revenueCollaboration and license revenue$229.00 KOther income (expense), net (calculated)Other income,net (calculated)−$66.20 M
Chart details

PTC Therapeutics, Inc. (PTCT) FY2026 Q3 P&L / Income Statement

Income statement for 2026-07-01 through 2026-09-30. View: Product and service (3 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Total revenues
357,807,000 US dollars
Total operating expenses
332,693,000 US dollars
Income from operations
25,114,000 US dollars
Other income (expense), net (calculated)
negative 66,202,000 US dollars
(Loss) income before income tax (expense) benefit
negative 41,088,000 US dollars
Income tax (expense) benefit
10,605,000 US dollars
Net (loss) income attributable to common stockholders
negative 51,693,000 US dollars
Net product revenue
275,894,000 US dollars
Collaboration and license revenue
229,000 US dollars
Royalty revenue
81,684,000 US dollars
Total operating expenses
332,693,000 US dollars

Chart connections

  • Revenue minus operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
PTC Therapeutics, Inc. (PTCT) FY2026 Q3 Revenue by Product and Service (3 categories) Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!